Yuxi Watson Biotechnology

Yuxi Watson Biotechnology is a leading Chinese biotechnology company specializing in the research, development, and manufacturing of human vaccines. As the core subsidiary of Walvax Biotechnology, the company operates large-scale production facilities in Yuxi, Yunnan Province. Its portfolio includes the first domestically developed 13-valent pneumococcal conjugate vaccine (PCV13) in China and a bivalent HPV vaccine. The company is dedicated to providing high-quality, affordable vaccines to address global public health challenges, with a strong focus on pediatric and infectious disease prevention. Yuxi Watson plays a pivotal role in China's vaccine industry and is actively expanding its presence in international markets through strategic partnerships.